Vertex Pharmaceuticals reported $1.16B in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acadia Pharmaceuticals ACAD:US USD -30360000 2.78M
Agios Pharmaceuticals AGIO:US USD -89109000 6.24M
Alnylam Pharmaceuticals ALNY:US USD -247440000 65.85M
Amgen AMGN:US USD 3.04B 460M
Arrowhead Research ARWR:US USD -81170000 10.86M
Biogen BIIB:US USD 992.8M 82.9M
Biomarin Pharmaceutical BMRN:US USD 22.38M 42.04M
Bluebird Bio BLUE:US USD -85093000 14.32M
Bristol Myers Squibb BMY:US USD 4.66B 663M
Gilead Sciences GILD:US USD 2.7B 667M
Insmed INSM:US USD -119864000 21.78M
Intercept Pharmaceuticals ICPT:US USD -10064000 808K
Johnson & Johnson JNJ:US USD 7.34B 1.2B
Moderna Inc MRNA:US USD 1.28B 1.24B
Neurocrine Biosciences NBIX:US USD 91.8M 33.2M
Novartis NOVN:VX USD 4.69B 34M
Pfizer PFE:US USD 6.94B 3.94B
Ptc Therapeutics PTCT:US USD -33710000 29.47M
Regeneron Pharmaceuticals REGN:US USD 1.33B 49.4M
Roche Holding ROG:VX 13.44B 2.56B
Sangamo Biosciences SGMO:US USD -51845000 8.99M
Sarepta Therapeutics SRPT:US USD -120652000 80.59M
Seattle Genetics SGEN:US USD -175213000 59.32M
Ultragenyx Pharmaceutical RARE:US USD -220372000 83.26M
United Therapeutics UTHR:US USD 327.2M 112.7M
Vertex Pharmaceuticals VRTX:US USD 1.16B 6.8M
YTE INCY:US USD 134.94M 141.85M